COVID-19 Vaccines

PreclinicalVaccine

UUniversity of British Columbia

COVID-19 Vaccines is one of 58 small molecule programs targeting Liver Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Liver DiseaseActive, not recruiting

COVID-19Active, not recruiting

Liver DiseasePreclinical

Active, not recruiting

COVID-19Preclinical

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Tricor

JJagotec

Preclinical

1 2

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 3

SARS-COV-2 VACCINE

Moderna

Preclinical

2 4

Statin

Bristol-Myers Squibb

Preclinical

1 5

Blood Taken

HHospices Civils de Lyon

Preclinical

1 6

Standard Preparation

LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Preclinical

1 7

COVID-19 Vaccines

UUniversity of British Columbia

Preclinical

10 8

Hydroxychloroquine Pill

UUniversity of Calgary

Preclinical

2 9

Disease-Modifying Anti-Rheumatic Drugs

Roche

Preclinical

1 10

Immunosuppressive

Chiesi Farmaceutici S.p.A.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1Recruiting

COVID-19

NCT07416539

Clinical

Trials by Indication[1]

COVID-1910 trials

Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians

Unknown status·—··NCT04706143·100 enrolled

National Project on Vaccines, COVID-19 and Frail Patients

Completed·AAzienda USL Reggio Emilia - IRCCS··NCT04848493·747 enrolled

Real-world Evidence of COVID-19 Vaccines Effectiveness

Terminated·IIvan S Moiseev··NCT04981405·182 enrolled

Show 7 more trials

COVID-19 Vaccine Effectiveness Among Health Workers in Georgia

Unknown status·NNational Center for Disease control and Public Health··NCT04868448·1,600 enrolled

Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

Recruiting·RRokote Laboratories Finland Oy·Phase 1·NCT07416539·20 enrolled

Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina

Unknown status·MMinistry of Public Health, Argentina·Phase 2·NCT04988048·1,760 enrolled

Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia

Completed·UUniversidad Nacional de Colombia··NCT04887246·4,078 enrolled

Allergy and COVID-19 Vaccines

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT05028257·117 enrolled

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

Unknown status·MMebo Research, Inc.··NCT04832932·2,000 enrolled

Genomics and COVID-19 Vaccine Adverse Events

Recruiting·UUniversity of British Columbia··NCT05212792·6,325 enrolled

Immunization1 trial

Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.

Completed·HHospital Clinica Nova··NCT05228912·1,870 enrolled

Vaccination1 trial

App-based Symptom Tracking After Corona Vaccination (CoCoV)

Unknown status·UUniversity of Ulm··NCT04686409·500 enrolled

Liver Disease1 trial

COVID-19 Vaccines in Patients With Chronic Liver Disease

Unknown status·—·N/A·NCT05017805·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 13 trial records for COVID-19 Vaccines. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — COVID-19 Vaccines compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for COVID-19 Vaccines. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of British Columbia company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Preclinical[1]
Company: UUniversity of British Columbia

COVID-19 Vaccines

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

COVID-1910 trials

Immunization1 trial

Vaccination1 trial

Liver Disease1 trial

References

Drug Info

Quick Facts

Related News